Genprex Inc (GNPX)
2.21
+0.09
(+4.25%)
USD |
NASDAQ |
Apr 26, 16:00
2.10
-0.11
(-4.98%)
After-Hours: 20:00
Genprex Max Drawdown (5Y): 99.12% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| March 31, 2024 | 99.12% |
| February 29, 2024 | 98.64% |
| January 31, 2024 | 98.49% |
| December 31, 2023 | 98.49% |
| November 30, 2023 | 98.49% |
| October 31, 2023 | 98.49% |
| September 30, 2023 | 98.49% |
| August 31, 2023 | 98.49% |
| July 31, 2023 | 98.49% |
| June 30, 2023 | 98.49% |
| May 31, 2023 | 98.49% |
| April 30, 2023 | 98.49% |
| March 31, 2023 | 98.49% |
| February 28, 2023 | 98.49% |
| January 31, 2023 | 98.49% |
| December 31, 2022 | 98.49% |
| November 30, 2022 | 98.49% |
| October 31, 2022 | 98.49% |
| September 30, 2022 | 98.49% |
| August 31, 2022 | 98.49% |
| July 31, 2022 | 98.49% |
| June 30, 2022 | 98.49% |
| May 31, 2022 | 98.49% |
| April 30, 2022 | 98.49% |
| March 31, 2022 | 98.49% |
| Date | Value |
|---|---|
| February 28, 2022 | 98.49% |
| January 31, 2022 | 98.49% |
| December 31, 2021 | 98.49% |
| November 30, 2021 | 98.49% |
| October 31, 2021 | 98.49% |
| September 30, 2021 | 98.49% |
| August 31, 2021 | 98.49% |
| July 31, 2021 | 98.49% |
| June 30, 2021 | 98.49% |
| May 31, 2021 | 98.49% |
| April 30, 2021 | 98.49% |
| March 31, 2021 | 98.49% |
| February 28, 2021 | 98.49% |
| January 31, 2021 | 98.49% |
| December 31, 2020 | 98.49% |
| November 30, 2020 | 98.49% |
| October 31, 2020 | 98.49% |
| September 30, 2020 | 98.49% |
| August 31, 2020 | 98.49% |
| July 31, 2020 | 98.49% |
| June 30, 2020 | 98.49% |
| May 31, 2020 | 98.49% |
| April 30, 2020 | 98.49% |
| March 31, 2020 | 98.49% |
| February 29, 2020 | 98.49% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
93.71%
Minimum
Apr 2019
99.12%
Maximum
Mar 2024
98.04%
Average
98.49%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
| Jaguar Health Inc | 100.00% |
| FibroGen Inc | 99.37% |
| BioXcel Therapeutics Inc | 96.98% |
| TFF Pharmaceuticals Inc | -- |
| 4D Molecular Therapeutics Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -39.58 |
| Beta (5Y) | -0.6097 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 325.6% |
| Historical Sharpe Ratio (5Y) | -0.146 |
| Historical Sortino (5Y) | -1.016 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.22% |